The FDA's safety review of mifepristone is expected to be completed by March 2027, according to a court filing in the U.S. District Court for the Western District of Louisiana.
Read →Loading search…
Loading search…
2 articles
The FDA's safety review of mifepristone is expected to be completed by March 2027, according to a court filing in the U.S. District Court for the Western District of Louisiana.
Read →The attorneys general of Louisiana, Alabama, and Arkansas filed a lawsuit on September 30 challenging the abortion 'shield laws' of New York, California, and Massachusetts, asking the Supreme Court to hear the case. The lawsuit argues that these shield laws protect abortion providers who mail abortion-inducing drugs to states with abortion restrictions, and the case has drawn responses from both sides, including statements from New York Attorney General Letitia James and pro-life leader Marjorie Dannenfelser.
Read →Showing 2 of 2